Tarka and Dyazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tarka (trandolapril; verapamil hydrochloride) and Dyazide (hydrochlorothiazide; triamterene). Common drug interactions include blood alkaline phosphatase decreased among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Tarka and Dyazide. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Tarka?

Tarka has active ingredients of trandolapril; verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 2,409 Tarka users. Check the latest studies of Tarka.

What is Dyazide?

Dyazide has active ingredients of hydrochlorothiazide; triamterene. It is often used in high blood pressure. eHealthMe is studying from 11,506 Dyazide users. Check the latest studies of Dyazide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

13 people who take Tarka and Dyazide together, and have interactions are studied.

Tarka and Dyazide drug interactions.

What are the common drug interactions of Tarka and Dyazide, by gender? *:

female:

  1. Blood alkaline phosphatase decreased
  2. Blood creatinine increased
  3. Blood urea increased
  4. Monocyte count increased
  5. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Platelet count decreased
  8. Red blood cell count decreased
  9. White blood cell count decreased
  10. Abdominal distension

male:

  1. Abdominal pain upper
  2. Blood glucose fluctuation
  3. Blood pressure fluctuation
  4. Diabetes mellitus insulin-dependent
  5. Headache (pain in head)
  6. Impotence (powerlessness)
  7. Jaundice cholestatic
  8. Vasodilatation (widening of blood vessels resulting from relaxation of smooth muscle cells within the vessel walls)
  9. Weight decreased

What are the common drug interactions of Tarka and Dyazide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood cholesterol increased
  2. Blood creatine phosphokinase increased
  3. Blood triglycerides increased
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  6. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  7. Diabetes mellitus non-insulin-dependent
  8. Hypertensive crisis
  9. Hypoglycaemia (deficiency of glucose in the bloodstream)
  10. Low density lipoprotein increased (cholesterol increased in blood)

50-59:

  1. Lipase increased
  2. Pancreatitis (inflammation of pancreas)
  3. Steatorrhoea (presence of excess fat in faeces)
  4. Abdominal pain upper

60+:

  1. Blood alkaline phosphatase decreased
  2. Blood creatinine increased
  3. Cardiomegaly (increased size of heart than normal)
  4. Fall
  5. Foot fracture
  6. Heart rate decreased
  7. Heart rate irregular
  8. Mean cell volume increased (more than normal average red blood cell volume)
  9. Wound
  10. Abdominal pain upper

What are the existing conditions these people have? *

  1. Ovarian Cancer (cancer of ovary): 3 people, 23.08%
  2. Weight Loss: 2 people, 15.38%
  3. Joint Swelling: 2 people, 15.38%
  4. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 15.38%
  5. Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 2 people, 15.38%
  6. Asthma: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Tarka and Dyazide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tarka and Dyazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tarka:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dyazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tarka and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dyazide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on trandolapril; verapamil hydrochloride and hydrochlorothiazide; triamterene (the active ingredients of Tarka and Dyazide, respectively), and Tarka and Dyazide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: